• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Osiris Therapeutics, Inc. (OSIR)

    -NasdaqGM
    14.94 Up 0.07(0.47%) Dec 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 24,308   7,849   1,263  
    Cost of Revenue6,656  2,551  531  
    Gross Profit 17,652   5,298   732  
    Operating Expenses
    Research Development4,952  5,501  4,340  
    Selling General and Administrative15,533  5,630  7,169  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (2,833) (5,833) (10,777)
    Income from Continuing Operations
    Total Other Income/Expenses Net414  49  100  
    Earnings Before Interest And Taxes(2,419)(5,784)(10,677)
    Interest Expense -   -   -  
    Income Before Tax(2,419)(5,784)(10,677)
    Income Tax Expense(1,326)(37)(775)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(1,093)(5,747)(9,902)
    Non-recurring Events
    Discontinued Operations42,731  (5,318)24,794  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 41,638   (11,065) 14,892  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 41,638   (11,065) 14,892  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.